Advertisement
JOGC

Economic Burden of Surgically Confirmed Endometriosis in Canada

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Objective

      To estimate the societal economic burden of illness caused by surgically confirmed endometriosis in Canada in 2009, including direct health care costs, lost productivity, and lost leisure time costs.

      Methods

      Using a cross-sectional design, direct health care resource use data were obtained from nine family physicians and nine gynaecologists from across Canada, who were experienced in the treatment of women with surgically confirmed endometriosis. Data on alternative treatments and health care providers, as well as work absenteeism, lost leisure time, and caregiver time were obtained from a convenience sample of 27 women with endometriosis treated at two gynaecology clinics in Alberta and Quebec. Unit costs were assigned to resource use items for treatment-seeking patients, and total costs for each resource use item were aggregated to estimate the societal costs of endometriosis in Canada in 2009, across all prevalent cases of surgically confirmed endometriosis.

      Results

      The estimated mean annual societal cost of endometriosis was $5200 per patient (95% CI $3700 to $7100), with lost productivity and lost leisure time costs accounting for 78%. Extrapolating these figures yields an estimated total annual cost to Canadian society of $1.8 billion (95% CI $1.3 billion to $2.4 billion) attributable to surgically confirmed endometriosis in Canada.

      Conclusion

      For some women, surgically confirmed endometriosis has a substantial negative impact that can result in suffering to the individual and her family, and lead to substantial productivity losses. Understanding the interplay between direct costs, lost productivity, and quality of life is critical for accurately identifying and evaluating effective treatments for this condition.

      Résumé

      Objectif

      Estimer le fardeau économique sociétal de la maladie lié à l’endométriose confirmée par chirurgie au Canada en 2009, y compris les coûts de santé directs, la perte de productivité et les coûts associés à la perte de temps de loisirs

      Méthodes

      Au moyen d’un modèle transversal, nous avons recueilli des données sur l’utilisation directe des ressources de santé auprès de neuf médecins de famille et de neuf gynécologues, de partout au Canada, qui disposaient d’une certaine expérience dans le traitement des femmes présentant une endométriose confirmée par chirurgie. Des données sur les fournisseurs de soins de santé et les traitements de rechange (ainsi que sur l’absentéisme au travail, la perte de temps de loisirs et le temps de soignant) ont été obtenues auprès d’un échantillon de commodité de 27 femmes qui présentaient une endométriose et qui ont été traitées dans deux cliniques de gynécologie en Alberta et au Québec. Des coûts unitaires ont été attribués aux articles « utilisation de ressources » pour les patientes cherchant à obtenir un traitement et les coûts totaux de chacun des articles « utilisation de ressources » ont été regroupés pour estimer les coûts sociétaux de l’endométriose au Canada en 2009, et ce, pour tous les cas prévalents d’endométriose confirmée par chirurgie

      Résultats

      Le coût sociétal annuel moyen estimé de l’endométriose était de 5 200 $ par patiente (IC à 95 %, 3 700 $ – 7 100 $), la perte de productivité et les coûts associés à la perte de temps de loisirs représentant 78 % de cette somme. L’extrapolation de ces chiffres donne, en ce qui concerne l’endométriose confirmée par chirurgie au Canada, un coût annuel total estimé pour la société canadienne de 1,8 milliard de dollars (IC à 95 %, 1,3 milliard de dollars – 2,4 milliards de dollars).

      Conclusion

      Chez certaines femmes, l’endométriose confirmée par chirurgie exerce un effet négatif substantiel qui peut donner lieu à de la souffrance pour la patiente et sa famille, ainsi que mener à des pertes de productivité considérables. La compréhension de l’influence réciproque qui s’exerce entre les coûts directs, la perte de productivité et la qualité de vie est cruciale pour permettre l’identification et l’évaluation avec précision des traitements efficaces contre cette pathologie.

      Key Words

      REFERENCES

        • Jones G.
        • Jenkinson C.
        • Kennedy S.
        The impact of endometriosis upon quality of life: a qualitative analysis.
        J Psychosom Obstet Gynaecol. 2004; 25: 123-133
        • Denny E.
        • Khan K.S.
        Systematic reviews of qualitative evidence: what are the experiences of women with endometriosis?.
        J Obstet Gynaecol. 2006; 26: 501-506
        • Gao X.
        • Outley J.
        • Botteman M.
        • Spalding J.
        • Simon J.A.
        • Pashos C.L.
        Economic burden of endometriosis.
        Fertil Steril. 2006; 86: 1561-1572
        • Jacobson T.Z.
        • Barlow D.H.
        • Garry R.
        • Koninckx P.
        Laparoscopic surgery for pelvic pain associated with endometriosis.
        Cochrane Database Syst Rev. 2001; 4CD001300
        • Royal College of Obstetricians and Gynaecologists
        The investigation and management of endometriosis. 2006 (Green-top Guideline No. 24, October 2006; rev October 2008)
        • The Practice Committee of the American Society for Reproductive Medicine
        Treatment of pelvic pain associated with endometriosis.
        Fertil Steril. 2008; 90: S260-S269
        • Simoens S.
        • Hummelshoj L.
        • D’Hooghe T.
        Endometriosis: cost estimates and methodological perspective.
        Hum Reprod Update. 2007; 13: 395-404
        • O’Cathain A.
        • Knowles E.
        • Nicholl J.
        Testing survey methodology to measure patients’ experiences and views of the emergency and urgent care system: telephone versus postal survey.
        BMC Med Res Methodol. 2010; 10: 52
        • Ontario Health Insurance Plan (OHIP)
        Schedule of Benefits for Physician Services under the Health Insurance Act. Ontario Ministry of Health and Long-term Care 2009. 2011 (Available at:) (Accessed on May 31, 2011)
        • Ontario Health Insurance Plan (OHIP)
        Schedule of Benefits for Laboratory Services. Ontario Ministry of Health and Long-term Care 2009. 2011 (Available at:) (Accessed June 7, 2011)
        • Ontario Case Costing Initiative (OCCI)
        Ontario Case Costing Initiative 2009. 2011 (Available at:) (Accessed on May 31, 2011)
        • Ontario Drug Benefit (ODB) Formulary Database
        Ontario Ministry of Health and Long-term Care 2009. 2011 (Available at:) (Accessed May 31, 2011)
        • Norfolk Pharmacy and Surgical Supplies
        Well.ca: Canada’s online health store. Norfolk Pharmacy and Surgical Supplies 2009. 2011 (Available at:) (Accessed May 31, 2011)
        • Manulife Financial
        Reasonable and customary fees for health practitioners. Manulife Financial 2009. 2011 (Available at:) (Accessed June 7, 2011)
        • Statistics Canada
        Labour force survey estimates (LFS), wages of employees by type of work, National Occupational Classification for Statistics (NOC-S), sex and age group, CANSIM database. Table 282–0069. Statistics Canada, 2009 (Available at:) (Accessed May 31, 2011)
        • Jowett S.
        • Bryan S.
        • Mahe I.
        • Brieger D.
        • Carlsson J.
        • Kartman B.
        • et al.
        A multinational investigation of time and traveling costs in attending anticoagulation clinics.
        Value Health. 2008; 11: 207-212
        • Statistics Canada
        Consumer Price Index, Health Care, Table 326-0020. Statistics Canada, 2009 (Available at:) (Accessed May 31, 2011)
        • Statistics Canada
        Estimates of population, by age group and sex for July 1, Canada, provinces and territories, annual (persons), 2008, Table 051–0001. Statistics Canada, Ottawa2009 (Available at:) (Accessed May 31, 2011)
        • Missmer S.A.
        • Hankinson S.E.
        • Spiegelman D.
        • Barbieri R.L.
        • Marshall L.M.
        • Hunter D.J.
        Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors.
        Am J Epidemiol. 2004; 160: 784-796
        • Johnson N.
        • Barlow D.
        • Lethaby A.
        • Tavender E.
        • Curr E.
        • Garry R.
        Surgical approach to hysterectomy for benign gynaecological disease.
        Cochrane Database of Syst Rev. 2006; CD003677
        • Garry R.
        Diagnosis of endometriosis and pelvic pain.
        Fertil Steril. 2006; 86: 1307-1309
        • Fourquet J.
        • Gao X.
        • Zavala D.
        • Orengo J.C.
        • Abac S.
        • Ruiz A.
        • et al.
        Patients’ report on how endometriosis affects health, work, and daily life.
        Fertil Steril. 2010; 93: 2424-2428
        • Hadfield R.
        • Mardon H.
        • Barlow D.
        • Kennedy S.
        Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK.
        Hum Reprod. 1996; 11: 878-880
        • Luisi S.
        • Lazzeri L.
        • Ciani V.
        • Petraglia F.
        Endometriosis in Italy: from cost estimates to new medical treatment.
        Gynecol Endocrinol. 2009; 25: 734-740
        • Leyland N.
        • Casper R.
        • Laberge P.
        • Singh S.S.
        Endometriosis: diagnosis and management. SOGC Clinical Practice Guidelines, No. 244, July 2010.
        J Obstet Gynaecol Can. 2010; 32: S1-S32
        • Statistics Canada
        Population 15 years and over by highest degree, certificate or diploma (1986 to 2006 Census). Statistics Canada, Ottawa2009 (Available at:) (Accessed May 31, 2011)
        • Stinnett A.A.
        • Paltiel A.D.
        Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means.
        Med Decis Making. 1997; 17: 483-489